Which hedge funds own TVTX? TRAVERE THERAPEUTICS INC, Q2 2026 13F holders
60 tracked hedge funds disclosed a position in TVTX (TRAVERE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $1.7bn in total. The largest holder by portfolio weight is Kynam Capital Management, LP at 6.3% of its book. 18 opened a new position this quarter: Capricorn Fund Managers Ltd, Arrowpoint Investment Partners (Singapore) Pte. Ltd., Integral Health Asset Management, LLC, Apis Capital Advisors, LLC. 14 exited: Superstring Capital Management LP, Context Capital Management, LLC, Soleus Capital Management, L.P..
- 60
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 18
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 14
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $117m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $122m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $1.7bn
- Combined value Sum of the holders' reported positions in the security.
- 4.8%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Superstring Capital Management LP | 2.2% | $3.1m |
| Context Capital Management, LLC | 1.5% | $66.9m |
| Soleus Capital Management, L.P. | 0.7% | $16.2m |
| RA Capital Management, L.P. | 0.2% | $22.2m |
| Bayforest Capital Ltd | 0.1% | $104k |
| PDT Partners, LLC | 0.1% | $1.8m |
| Y-Intercept (Hong Kong) Ltd | 0.07% | $3.5m |
| Caption Management, LLC | 0.04% | $743k |
| Entropy Technologies, LP | 0.03% | $697k |
| Cinctive Capital Management LP | 0.03% | $415k |
| Capital Fund Management S.A. | 0.02% | $2.6m |
| Voloridge Investment Management, LLC | 0.01% | $3.4m |
| Farallon Capital Management, L.L.C. | 0.0% | $357k |
| Hudson Bay Capital Management LP | 0.0% | $194k |
Ownership over time
Who discovered TVTX first? Beta
The run: Q2 2025 → Q3 2026, +298%
| Rock Springs Capital Management LP high conviction | Q2 2024 | 1.8% | +4.6 pts |
| Eversept Partners, LP | Q1 2025 | 2.0% | +3.7 pts |
| Affinity Asset Advisors, LLC | Q4 2024 | 3.1% | +3.1 pts |
| Superstring Capital Management LP high conviction | Q1 2025 | 5.1% | +2.8 pts |
| Perceptive Advisors LLC high conviction | Q3 2025 | 0.5% | +2.5 pts |
| Exome Asset Management LLC | Q1 2025 | 1.9% | +2.4 pts |
| Birchview Capital, LP | Q3 2024 | 1.5% | +2.0 pts |
| Parkman Healthcare Partners LLC | Q2 2024 | 1.4% | +1.8 pts |
| Graham Capital Management, L.P. | Q4 2024 | 1.2% | +1.4 pts |
| Sphera Funds Management Ltd. | Q2 2025 | 1.3% | −0.4 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.